Skip to main content

Table 1 Baseline characteristics of study participants

From: A pragmatic, randomized, controlled study evaluating the impact of access to smoking cessation pharmacotherapy coverage on the proportion of successful quitters in a Canadian population of smokers motivated to quit (ACCESSATION)

 

Full coverage (n = 696)

No coverage (n = 684)

Demographic characteristics

 Age, mean, years (SD)

46.5 (12.3)

46.7 (12.3)

 Gender, n (%)

  

  Male

354 (50.9)

337 (49.3)

  Female

342 (49.1)

347 (50.7)

 Race, n (%)

  

  White

664 (95.4)

660 (96.5)

  Black

11 (1.6)

6 (0.9)

  Asian

15 (2.2)

13 (1.9)

  Other

6 (0.9)

5 (0.7)

 Educational level, years, n (%)

  

  <10

46 (6.6)

57 (8.3)

  10–12

321 (46.1)

305 (44.6)

  13–16

273 (39.2)

257 (37.6)

  >16

56 (8.0)

61 (8.9)

 Employment status, n (%)

  

  Full-time employed

298 (42.8)

297 (43.4)

  Part-time employed

79 (11.4)

77 (11.3)

  Not employed

319 (45.8)

308 (45.0)

 Insurance type, n (%)

  

  Private insurance

51 (7.3)

53 (7.7)

  Government-provided insurance

143 (20.5)

137 (20.0)

  No drug insurance

484 (69.5)

479 (70.0)

  Other type of insurance

18 (2.6)

14 (2.0)

 Household income, n (%)

  

  <$15,000 CAD

58 (8.3)

92 (9.1)

  $15,000– <$25,000 CAD

260 (37.4)

246 (36.0)

  $25,000– <$50,000 CAD

203 (29.2)

218 (31.9)

  $50,000– <$75,000 CAD

78 (11.2)

62 (9.1)

  $75,000– <$100,000 CAD

32 (4.6)

31 (4.5)

  >$100,000 CAD

22 (3.2)

17 (2.5)

 Body mass index (kg/m2), mean (SD)

28.1 (6.3)

28.3 (6.5)

Smoking history

 Age at onset of smoking, years, mean (SD)

15.5 (4.5)

15.5 (4.0)

 Cigarette pack years, mean (SD)

34.8 (21.8)

34.6 (21.5)

 Cigarettes/day (past month), mean (range)

22.2 (9.5)

21.5 (8.3)

 FTND score, mean (SD)*

5.9 (2.1)

5.9 (2.1)

 Number of lifetime serious quit attempts – any method, n (%)

  

  0

93 (13.4)

64 (9.4)

  1

163 (23.4)

166 (24.3)

  2

143 (20.5)

148 (21.6)

  ≥3

297 (42.7)

306 (44.7)

Comorbidities

 COPD

65 (9.3)

77 (11.3)

 Lung cancer

0

2 (0.3)

 Coronary heart disease

18 (2.6)

17 (2.5)

 Stroke

1 (0.1)

2 (0.3)

 Asthma exacerbation

76 (10.9)

66 (9.6)

 Past psychiatric disorder

73 (10.5)

65 (9.5)

 Current psychiatric disorder

230 (33)

213 (31.1)

 Current depression

109 (15.7)

106 (15.5)

 Current anxiety/anxiety disorder

66 (9.5)

61 (9.0)

  1. CAD = Canadian dollar; COPD = chronic obstructive pulmonary disease; FTND = Fagerström Test for Nicotine Dependence; SD = standard deviation; SES = socioeconomic status.
  2. *Scores range from 0 to 10, with higher scores indicating greater nicotine dependence. Comorbidities reported as “present” in subjects’ medical history at the time of the screening/randomization visit.